摘要
目的探讨2型糖尿病治疗中应用消渴丸的临床价值。方法于2018年1月—2019年1月该院接收的82例2型糖尿病患者作为此次研究中的分析对象,通过电脑随机法进行分组对照,即常规组(予以格列齐特口服治疗)、研究组(予以消渴丸口服),各41例。结果研究组临床疗效显著高于常规组,组间差异有统计学意义(P<0.05);研究组餐后血糖、空腹血糖、糖化血红蛋白均低于常规组,组间差异有统计学意义(P<0.05);研究组不良反应发生率明显低于常规组,组间差异有统计学意义(P<0.05)。结论对于2型糖尿病患者而言,消渴丸治疗价值更高,不仅可以降低患者血糖水平,而且还可以减少不良反应,效果确切,值得在临床中借鉴、推广。
Objective To explore the clinical value of Xiaoke Pill in the treatment of type 2 diabetes mellitus. Methods A total of 82 patients with type 2 diabetes mellitusreceived in our hospital from January 2018 to January 2019 were divided into two groups by computer random method: conventional group (treated with gliclazide orally) and research group (treated with Xiaoke Pill orally), 41 cases in each group. Results The clinical efficacy of the research group was significantly higher than that of the conventional group, with significant difference between the two groups(P<0.05). Postprandial blood glucose, fasting blood glucose and glycosylated hemoglobin in the research group were lower than those in the conventional group, with significant difference between the two groups (P<0.05). The incidence of adverse reactions in the research group was significantly lower than that in the conventional group, with significant difference between the two groups(P<0.05). Conclusion For type 2 diabetes mellitus patients, Xiaoke Pill has high therapeutic value. It can not only reduce blood sugar level, but also reduce adverse reactions. The effect is exact. It is worth learning and promoting in clinical practice.
作者
贾素花
JIA Su-hua(Guangrao County Grand Dock Central Health Center, Dongying, Shandong Province, 257338 China)
出处
《糖尿病新世界》
2019年第13期19-20,23,共3页
Diabetes New World Magazine
关键词
2型糖尿病
消渴丸
应用价值
Type 2 diabetes mellitus
Xiaoke Pill
Application value
